Biological Containment Isolation System (BCIS)
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Army Contracting Command-Aberdeen Proving Ground (ACC-APG), on behalf of the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Protection (JPM CBRN P), is seeking prototype solutions for a Biological Containment Isolation System (BCIS). This effort, conducted under Other Transaction Authority (OTA) (10 U.S.C. § 4022), aims to develop a modular, field-installable kit to convert existing USAF TMT60 positive-pressure tent shelters into negative-pressure, multi-patient isolation systems for managing High Consequence Infectious Diseases (HCID). Solution Briefs are due by June 09, 2026, at 1700 EST.
Purpose & Scope
The primary objective is to acquire innovative prototype solutions for a BCIS that can rapidly establish negative-pressure isolation capabilities within the standard TMT60 tent system. This system will enable medical staff to monitor and treat HCID patients in austere environments while minimizing infection risk and reducing transmission. The solution must be reversible, allowing the TMT60 to return to its original configuration.
Key Requirements
Proposed solutions must meet critical threshold requirements, including:
- Negative Pressure: -2.5 Pa (approximately -0.01 in. w.g.) differential.
- Air Exchange: ≥12 Air Changes per Hour (ACH).
- Filtration: 99.97% efficiency for 0.3-micron particles.
- Compatibility: Seamless integration with, and reversibility for, the standard TMT60 tent system.
- Occupancy: An isolation room capable of accommodating at least 5 patients (specifically, two single-patient HCID units and four litters as per the latest SOO).
Acquisition Strategy & Contract Details
This acquisition follows a two-step process with the intent to award multiple Prototype OTAs. The effort is phased:
- Phase I: Up to three contractors will be selected to deliver three prototypes (minimum TRL 6) within 60-90 days of award.
- Phase II: A down-selection to up to two contractors will occur, requiring delivery of five prototypes (minimum TRL 7) for further testing and demonstrations. Successful completion of the prototype phase may lead to a non-competitive follow-on production contract for up to 15 units. The Government strongly prefers Unlimited Rights for all technical data and intellectual property; less than Government Purpose Rights (GPR) may negatively impact evaluation.
Eligibility & Evaluation
This opportunity encourages significant participation from non-traditional defense contractors and/or small businesses, aligning with 10 U.S.C. § 4022(d)(1).
- Step 1 (Solution Brief) Evaluation: Based on Threshold Assertions (Pass/Fail), OTA Eligibility (Pass/Fail), Technical Merit, and Programmatic Viability (Rough Order of Magnitude cost estimate).
- Phase I to Phase II Evaluation: Considers Performance, Technical Maturity, Item Cost, and Risk Reduction.
- Final Prototype Selection: Based on Performance, User Feedback, and Affordability.
Submission & Deadlines
Interested parties must submit a Solution Brief package via email to the listed Points of Contact. The package consists of a Solution Brief (15-page limit, excluding ROM) and a Supporting Data Package (no page limit). Response Date: June 09, 2026, 1700 EST. Points of Contact: Dan Adams (dan.l.adams2.civ@army.mil) and Andy Rhodes (andrew.r.rhodes10.civ@army.mil). Full details are in the attached Call for Solutions (CFS) document.